GURUFOCUS.COM » STOCK LIST » Technology » Software » Synopsys Inc (NAS:SNPS) » Definitions » Cash Flow from Operations

Synopsys (Synopsys) Cash Flow from Operations : $1,501 Mil (TTM As of Jan. 2024)


View and export this data going back to 1992. Start your Free Trial

What is Synopsys Cash Flow from Operations?

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the three months ended in Jan. 2024, Synopsys's Net Income From Continuing Operations was $446 Mil. Its Depreciation, Depletion and Amortization was $63 Mil. Its Change In Working Capital was $-671 Mil. Its cash flow from deferred tax was $-101 Mil. Its Cash from Discontinued Operating Activities was $0 Mil. Its Asset Impairment Charge was $0 Mil. Its Stock Based Compensation was $181 Mil. And its Cash Flow from Others was $-6 Mil. In all, Synopsys's Cash Flow from Operations for the three months ended in Jan. 2024 was $-88 Mil.


Synopsys Cash Flow from Operations Historical Data

The historical data trend for Synopsys's Cash Flow from Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synopsys Cash Flow from Operations Chart

Synopsys Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Cash Flow from Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only 800.51 991.31 1,492.62 1,738.90 1,703.27

Synopsys Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Cash Flow from Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 114.75 702.94 559.52 326.06 -87.79

Synopsys Cash Flow from Operations Calculation

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

Synopsys's Cash Flow from Operations for the fiscal year that ended in Oct. 2023 is calculated as:

Synopsys's Cash Flow from Operations for the quarter that ended in Jan. 2024 is:


Cash Flow from Operations for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,501 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Synopsys  (NAS:SNPS) Cash Flow from Operations Explanation

For companies reported in indirect method, cash flow from operations contains six items:

1. Net Income From Continuing Operations:
Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Synopsys's net income from continuing operations for the three months ended in Jan. 2024 was $446 Mil.

2. Depreciation, Depletion and Amortization:
Depreciation is a present expense that accounts for the past cost of an asset that is now providing benefits.
Depletion and amortization are synonyms for depreciation.
Generally:
The term depreciation is used when discussing man made tangible assets
The term depletion is used when discussing natural tangible assets
The term amortization is used when discussing intangible assets

Synopsys's depreciation, depletion and amortization for the three months ended in Jan. 2024 was $63 Mil.

3. Change In Working Capital:
Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities. Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow.

Synopsys's change in working capital for the three months ended in Jan. 2024 was $-671 Mil. It means Synopsys's working capital declined by $671 Mil from Oct. 2023 to Jan. 2024 .

4. Deferred Tax:
It is the cash flow generated from deferred tax.

Synopsys's cash flow from deferred tax for the three months ended in Jan. 2024 was $-101 Mil.

5. Cash from Discontinued Operating Activities:
Net cash from all of the entity's discontinued operating activities.

Synopsys's cash from discontinued operating Activities for the three months ended in Jan. 2024 was $0 Mil.

6. Asset Impairment Charge:
It is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Synopsys's asset impairment charge for the three months ended in Jan. 2024 was $0 Mil.

7. Stock Based Compensation:
It is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Synopsys's stock based compensation for the three months ended in Jan. 2024 was $181 Mil.

8. Cash Flow from Others:
These are cash differences caused by the change of inventory, accounts payable, accounts receivable etc. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its account receivables will rise, and its cash position will grow more slowly (or even shrink).

Synopsys's cash flow from others for the three months ended in Jan. 2024 was $-6 Mil.


Synopsys Cash Flow from Operations Related Terms

Thank you for viewing the detailed overview of Synopsys's Cash Flow from Operations provided by GuruFocus.com. Please click on the following links to see related term pages.


Synopsys (Synopsys) Business Description

Industry
Address
675 Almanor Avenue, Sunnyvale, CA, USA, 94085
Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Executives
Mercedes Johnson director MICRON TECHNOLOGY, INC, 8000 S FEDERAL WAY, MS 1-557, BOISE ID 83716
Richard S. Mahoney officer: Chief Revenue Officer 2600 ANSYS DRIVE, CANONSBURG PA 15317
Runkel John F Jr officer: General Counsel & C/O INTUITIVE SURGICAL, INC., 1266 KIFER ROAD, SUNNYVALE CA 94086
Sudhindra Kankanwadi officer: VP and Corporate Controller 690 E MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Robert G Painter director C/O TRIMBLE INC., 935 STEWART DRIVE, SUNNYVALE CA 94085
Geus Aart De director, officer: Chairman of the Board & Co-CEO
Sassine Ghazi officer: Chief Operating Officer 3075 W RAY ROAD, SUITE 528, THE PARK AT SAN TAN, CHANDLER AZ 85226
Shelagh Glaser officer: CFO ZENDESK, INC., 989 MARKET STREET, SAN FRANCISCO CA 94103
Roy Vallee director 2211 S 47TH ST, PHOENIX AZ 85034
Joseph W Logan officer: EVP, Sales & Corp Marketing 700 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Chrysostomos L Nikias director UNIVERSITY OF SOUTHERN CALIFORNIA, 3551 TROUSEDALE, BOVARD ADM 102, LOS ANGELES CA 90089-4019
Trac Pham officer: CFO 700 E. MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Luis Borgen director 58 SUNSET RIDGE LANE, BOLTON MA 01740
Marc N Casper director C/O THERMO FISHER SCIENTIFIC, 168 THIRD AVENUE, WALTHAM MA 02451
Chi-foon Chan director, officer: Co-CEO & President

Synopsys (Synopsys) Headlines

From GuruFocus

Q4 2023 Synopsys Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q3 2022 Synopsys Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q4 2021 Synopsys Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q1 2022 Synopsys Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q4 2022 Synopsys Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2022 Synopsys Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024